MA53914A - Polymorphes cristallins d'inhibiteurs de la tyrosine kinase de bruton - Google Patents
Polymorphes cristallins d'inhibiteurs de la tyrosine kinase de brutonInfo
- Publication number
- MA53914A MA53914A MA053914A MA53914A MA53914A MA 53914 A MA53914 A MA 53914A MA 053914 A MA053914 A MA 053914A MA 53914 A MA53914 A MA 53914A MA 53914 A MA53914 A MA 53914A
- Authority
- MA
- Morocco
- Prior art keywords
- bruton
- tyrosine kinase
- kinase inhibitors
- crystalline polymorphs
- polymorphs
- Prior art date
Links
- 102000001714 Agammaglobulinaemia Tyrosine Kinase Human genes 0.000 title 1
- 108010029445 Agammaglobulinaemia Tyrosine Kinase Proteins 0.000 title 1
- 229940121358 tyrosine kinase inhibitor Drugs 0.000 title 1
- 239000005483 tyrosine kinase inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862745741P | 2018-10-15 | 2018-10-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA53914A true MA53914A (fr) | 2021-08-25 |
Family
ID=68426868
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA053914A MA53914A (fr) | 2018-10-15 | 2019-10-15 | Polymorphes cristallins d'inhibiteurs de la tyrosine kinase de bruton |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US11820760B2 (fr) |
| EP (1) | EP3866926A1 (fr) |
| JP (1) | JP7476214B2 (fr) |
| MA (1) | MA53914A (fr) |
| WO (1) | WO2020081514A1 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2025013208A (es) * | 2023-05-05 | 2026-02-03 | Biogen Ma Inc | Inhibidor de btk para el tratamiento de la esclerosis múltiple |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4938949A (en) | 1988-09-12 | 1990-07-03 | University Of New York | Treatment of damaged bone marrow and dosage units therefor |
| JP6139690B2 (ja) | 2012-10-26 | 2017-05-31 | エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ | ブルートンチロシンキナーゼの阻害剤 |
| KR20160063366A (ko) * | 2013-10-21 | 2016-06-03 | 메르크 파텐트 게엠베하 | Btk 저해제로서 헤테로아릴 화합물 및 이들의 용도 |
| HRP20181109T1 (hr) * | 2013-12-11 | 2018-11-02 | Biogen Ma Inc. | Spojevi biarila korisni za liječenje ljudskih bolesti u onkologiji, neurologiji i imunologiji |
| WO2016201280A1 (fr) | 2015-06-10 | 2016-12-15 | Biogen Ma Inc. | Formes et compositions d'inhibiteurs biaryles de la tyrosine kinase de bruton |
| SI3609886T1 (sl) * | 2017-04-14 | 2024-05-31 | Biogen Ma Inc. | Analogi benzoazepina kot inhibicijska sredstva za brutonovo tirozin kinazo |
| EP3793994B1 (fr) | 2018-05-14 | 2023-08-23 | Biogen MA Inc. | Agents inhibiteurs de la tyrosine kinase de bruton |
-
2019
- 2019-10-15 MA MA053914A patent/MA53914A/fr unknown
- 2019-10-15 EP EP19797924.8A patent/EP3866926A1/fr active Pending
- 2019-10-15 JP JP2021545281A patent/JP7476214B2/ja active Active
- 2019-10-15 WO PCT/US2019/056242 patent/WO2020081514A1/fr not_active Ceased
- 2019-10-15 US US17/283,301 patent/US11820760B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP7476214B2 (ja) | 2024-04-30 |
| WO2020081514A1 (fr) | 2020-04-23 |
| US20210387972A1 (en) | 2021-12-16 |
| US11820760B2 (en) | 2023-11-21 |
| WO2020081514A9 (fr) | 2020-05-22 |
| EP3866926A1 (fr) | 2021-08-25 |
| JP2022502516A (ja) | 2022-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3870178A4 (fr) | Formes cristallines d'inhibiteurs de mnk | |
| MA51619A (fr) | Inhibiteurs de la protéine kinase dépendante de l'adn | |
| EP3399968A4 (fr) | Inhibiteurs sélectifs de mutants cliniquement importants de la tyrosine kinase de l'egfr | |
| EP3873477A4 (fr) | Inhibiteurs de la kinase cycline-dépendante 7 (cdk7) | |
| DK3265084T3 (da) | Farmaceutiske formuleringer af Bruton's tyrosinkinase-hæmmer | |
| EP3492462A4 (fr) | Composé amino pyrimidine pour inhiber l'activité de la protéine tyrosine kinase | |
| ZA201903932B (en) | Imidazopyrazine inhibitors of bruton's tyrosine kinase | |
| IL270693A (en) | Glucuronide prodrugs of janus kinase inhibitors | |
| IL255831A (en) | Inhibitors of bruton's tyrosine kinase | |
| EP3405192A4 (fr) | Inhibiteurs de la tyrosine kinase de bruton | |
| EP3414234A4 (fr) | Inhibiteurs de la tyrosine kinase de bruton | |
| MA41828A (fr) | Co-cristaux d'un inhibiteur de la tyrosine kinase de bruton | |
| MA41350A (fr) | Synthèse d'un inhibiteur de la tyrosine kinase de bruton | |
| ZA201903694B (en) | Inhibitors of bruton's tyrosine kinase | |
| EP3740206A4 (fr) | Inhibiteurs de la kinase cycline-dépendante 7 (cdk7) | |
| MA52629A (fr) | Agents inhibiteurs de la tyrosine kinase de bruton | |
| MA42510A (fr) | Formes et compositions d'inhibiteurs biaryles de la tyrosine kinase de bruton | |
| MA42509A (fr) | Formes d'adipate et compositions d'inhibiteurs de biaryle de la tyrosine kinase de bruton | |
| EP3962908A4 (fr) | Inhibiteurs hétérocycliques de tyrosine kinase | |
| EP3969111A4 (fr) | Formulations inhalables pour l'inhibition de kinases | |
| EP3730483A4 (fr) | Classe d'inhibiteurs de kinase dérivés de pyrimidine | |
| EP3765008A4 (fr) | Inhibiteurs hétérocycliques de la kinase atr | |
| IL287745A (en) | Methods of treating sjögren's syndrome using a bruton's tyrosine kinase inhibitor | |
| IL269152A (en) | Broughton's kinase designers | |
| EP3833778A4 (fr) | Détection multiplexe d'acides nucléiques |